Product Information
RIVELSA TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.5932 per EA under NDC 00093603182. Its NADAC has been published 86 times since Apr 17, 2024.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093603182
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Authorized Generic (NDA)
FDA Application
NDA204061On Market Since
4/3/2017
Price Statistics
The NADAC for RIVELSA TABLET has been published 86 times since Apr 17, 2024, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5932 per EA |
|---|---|
| All-time high | $1.9332 (Dec 11, 2024) |
| All-time low | $1.2238 (Jun 18, 2025) |
| 52-week high | $1.7000 |
| 52-week low | $1.2238 |
| Median price | $1.6761 |
| Average price | $1.5987 |
| Largest weekly change | +32.8% (May 20, 2026) |
| Weeks tracked | 86 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVELSA TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIVELSA TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.5932 per EA (NDC 00093603182), effective Jun 24, 2026.
How has the price of RIVELSA TABLET changed over time?
Over the history we have for it, the NADAC for RIVELSA TABLET has declined 16.3%. It has been tracked across 86 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for RIVELSA TABLET?
Since Apr 17, 2024, the NADAC for RIVELSA TABLET has ranged from a low of $1.2238 (Jun 18, 2025) to a high of $1.9332 (Dec 11, 2024), with a median of $1.6761 per EA.
Are there cheaper alternatives to RIVELSA TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CAMRESE LO TABLET, is $0.2436 per EA — about 85% below RIVELSA TABLET.
Who manufactures RIVELSA TABLET?
RIVELSA TABLET (NDC 00093603182) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification